Fig. 2.
Incidence of grade ≥ 3 hematologic toxicity following chemo-radiotherapy for cervical cancer in randomised controlled trials investigating bone marrow-sparing chemo-radiotherapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.